While supporting the alteration of pH as a part of the complex drug resistance mechanisms of tumor cells, our study also provided some insights into the optimal structural features and suitable physicochemical properties for designing drug-like PD-L1 ligands as inhibitors of the PD-1/PD-L1 complex that may be resilient to tumor microenvironmental pH conditions. Here, PDCD1 is linked to neoplasm.